Aokesi Medical: Multiple directors plan to reduce their shareholding by no more than 0.18% of the company's shares.

OJ Medical announced that due to their own capital needs, director and general manager Qiu Zhiye, financial director Wang Ling, director and deputy general manager Song Tianxi, and Tian Guofeng plan to reduce their holdings of the company's shares. Qiu Zhiye plans to reduce his holdings by no more than 95,000 shares, Wang Ling plans to reduce her holdings by no more than 70,312 shares, Song Tianxi plans to reduce his holdings by no more than 50,000 shares, and Tian Guofeng plans to reduce his holdings by no more than 37,500 shares. The reduction period is from December 3, 2025 to March 3, 2026, with the source of the shares being from equity incentives.